Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients.

Background: Primary goal of this randomized, double-blind, placebo-controlled crossover study of Renadyl in end-stage renal disease patients was to assess the safety and efficacy of Renadyl measured through improvement in quality of life or reduction in levels of known uremic toxins. Secondary goal...

Descripción completa

Detalles Bibliográficos

Publicado en:	BioMed Research International Vol. 2014; pp. 568571 - 568572
Autores principales:	Natarajan, Ranganathan, Pechenyak, Bohdan, Vyas, Usha, Ranganathan, Pari, Weinberg, Alan, Liang, Peter, Mallappallil, Mary C, Norin, Allen J, Friedman, Eli A, Saggi, Subodh J
Formato:	Journal Article
Publicado:	Wiley-Blackwell 2014
Acceso en línea:	Ver este registro en EBSCOhost